Clinically Actionable Insights into Initial and Matched Recurrent Glioblastomas to Inform Novel Treatment Approaches

Glioblastoma is the most common primary adult brain tumour, and despite optimal treatment, the median survival is 12–15 months. Patients with matched recurrent glioblastomas were investigated to try to find actionable mutations. Tumours were profiled using a validated DNA-based gene panel. Copy numb...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Oncol
Main Authors: Ellis, H. P., McInerney, C. E., Schrimpf, D., Sahm, F., Stupnikov, A., Wadsley, M., Wragg, C., White, P., Prise, K. M., McArt, D. G., Kurian, K. M.
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi 2019
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7012245/
https://ncbi.nlm.nih.gov/pubmed/32082376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/4878547
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares